Description
GLP-3 Retatrutide 20 MG
GLP3 is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This tri-agonist approach is being researched as the next frontier in metabolic peptide science, leveraging three complementary pathways for maximal metabolic modulation.
Molecular Profile:
- Classification: Triple GLP-1/GIP/Glucagon Receptor Agonist
- Targets: GLP-1 + GIP + GCG
- Mechanism: Tri-receptor incretin and glucagon activation
Research Applications:
- Triple receptor synergy versus dual/mono agonists
- Enhanced energy expenditure via glucagon receptor activation
- Superior body composition changes in preclinical models
- Hepatic lipid metabolism and NASH/NAFLD research
- Thermogenesis and brown adipose tissue activation
- Long-term metabolic homeostasis studies
Quality Standards:
- Purity: ≥99% verified by HPLC
- Third-party tested with COA included
- Available in 4 sizes for dose-response studies
FOR RESEARCH USE ONLY. Not for human consumption.
